AstraZeneca Plc AZN released topline data from the Phase 3 program for efzimfotase alfa (ALXN1850) in the broad ...

OK! can reveal experts are warning the blockbuster weight-loss injections now sweeping Hollywood could carry a troubling ...

The intricate relationship between chronic kidney disease (CKD) and bone mineral density (BMD) is an area of burgeoning clinical and research interest. CKD is characterised by a progressive loss of ...

Clinical research has long focused on ways to harness the actions of the immune system. From vaccines to immunotherapies, researchers have used their knowledge of the immune system to develop ...

Researchers have shown that a naturally occurring peptide (small protein) holds promise as a new therapeutic for osteoporosis and other disorders that feature bone loss, with distinct advantages over ...

Plenty of lifestyle and health factors can put you on a fast track to osteoporosis.

Baylor College of Medicine has received new funding from the National Institutes of Health for two consortia in the Rare Diseases Clinical Research Network: $7.4 million over five years to renew the ...

March 16 (Reuters) - BioMarin Pharmaceutical will discontinue mid-stage trials of its bone disorder treatment after reports ...

Lowering blood pressure and cholesterol levels, quitting smoking, managing diabetes: these evidence-backed approaches remain key ways to reduce the risk of cardiovascular disease (SN: 11/9/15). But an ...

The term “rare blood disorders” describes less common conditions that affect blood cells’ ability to function correctly. Myeloproliferative disorders and lymphoproliferative disorders are two types of ...